GENERIC VS BRAND NAME LEVOTHYROXINE

通用名与品牌名左旋甲状腺素

• 批准号: 7607295
• 负责人: Rosalind Brown
• 金额: $ 3.18万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607295
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Funding; Generic Drugs; Grant; Institution; Names; Preparation; Research; Research Personnel; Resources; Source; Thyrotropin; Thyroxine; United States Food and Drug Administration; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The specific aim of this study is to determine whether there is a significant difference in thyroid stimulating hormone levels between two different preparations of levothyroxine that are declared therapeutically equivalent by the FDA.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的具体目的是确定 FDA 宣布具有治疗等效性的两种不同左旋甲状腺素制剂之间的促甲状腺激素水平是否存在显着差异。